• OPEN AN ACCOUNT
Indian Indices
Nifty
25,050.55 69.90
(0.28%)
Sensex
81,857.84 213.45
( 0.26%)
Bank Nifty
55,698.50 -166.65
( -0.30%)
Nifty IT
35,690.05 933.35
( 2.69%)
Global Indices
Nasdaq
44,922.30 10.50
(0.02%)
Dow Jones
6,445.50 -35.75
(-0.55%)
Hang Seng
42,914.69 -631.60
(-1.45%)
Nikkei 225
9,157.74 18.84
(0.21%)
Forex
USD-INR
87.37 -0.14
(-0.16%)
EUR-INR
102.05 -0.35
(-0.35%)
GBP-INR
118.24 -0.32
(-0.27%)
JPY-INR
0.59 0.00
(-0.46%)

EQUITY - MARKET SCREENER

IOL Chemicals & Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524164
INE485C01029
57.487133
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
IOLCP
27.09
2854.56
EPS(TTM)
Face Value()
Div & Yield %
3.59
2
0.82
 

Shri Keshav Cements & Infra Ltd - Board Meeting Outcome for Outcome Of Board Meeting Held On 12/08/2025
Aug 12,2025
At the meeting of the Board of Directors of the Company held today 12th August 2025 the following items of business were transacted.- 1. Considered and approved the Un-audited Financial Results and segment-wise Revenue Results for the quarter ended 30th June 2025. 2. Considered and approved the Directors Report for the Financial Year 2024-25. 3. Fixed the Day Date Time and Venue of 32nd Annual General Meeting of the Company. 4. Considered the appointment of M/s. Akshay Jadhav & Associates Company Secretaries as the Secretarial Auditor of the Company for a period of 5 Financial Year subject to the approval of shareholders in the ensuing AGM. 5. Considered the Re-appoint M/s. Santosh Kalburgi & Co. Cost Accountants Bangalore as Cost Auditors of the Company for the FY 2025-26. 6. Considered the alteration object clause of the Memorandum of Association of the company subject to the approval of shareholders in the ensuing AGM. This is for your kind information.